Technology | April 14, 2011

FDA Clears Brachytherapy Treatment Planning Software

April 14, 2011 – The U.S Food and Drug Administration (FDA) has cleared a new brachytherapy treatment planning system for permanent seed implants. The MIM Symphony module, from MIM Software, provides a powerful combination of tools to benefit radiation oncologists working with brachytherapy.

MRI, CT and even molecular imaging can now be seamlessly integrated into treatment planning for increased quality assurance.

“Brachytherapists can now enjoy the same image display, fusion and manipulation tools as their colleagues in radiology, and the same contouring tools as their colleagues performing IMRT – all directly integrated into the brachytherapy treatment planning software,” said Jonathan Piper, director of research and business development at MIM Software.

Key to the software is the new ReSlicer tool. For treatments requiring needle insertions that aren’t precisely perpendicular to the imaging plane, ReSlicer allows images to be quickly and easily reoriented, ensuring accurate planning and dosimetry for otherwise complicated plans. The tool adds confidence and simplicity to breast, lung, liver and other treatments.

“Our goal was to achieve totally flexible seed placement,” Piper said. “The use of ReSlicer in conjunction with thin-slice imaging allows for more precise planning and better orientation of seeds within the patient. In addition, fusion with mo¬dalities such as MRI offers more accurate contouring of targets and the possibility of dose escalation.”

The software seamlessly integrates many of the tools found in MIM Maestro, the company’s radiation oncology product. Using dose accumulation, it can sum a brachytherapy plan with any other DICOM dose file, giving an accurate representation of the full dose delivered to the patient. This can be essential to identifying and compensating for hot spots and underdoses, and provides much more confidence than reviewing two separate dose volume histograms.

Post-implant quality assurance is much more accurate. Multi-modality fusion allows either the original planning image or a separate post-implant image, such as an MRI, to be registered to a post-implant CT for more reliable target contouring. Combined with seed localization accuracy, which exceeds the resolution of the CT image, post-implant dosimetry is both easy and exact.

For more information: www.mimsoftware.com

Related Content

Kubtec Introduces Automatic Specimen Alert to Mozart 3-D Tomosynthesis System
Technology | Breast Imaging | August 23, 2017
Kubtec announced that it has developed a unique solution to a potential problem faced by operating room (OR) staff when...
Comparison of Screening Recommendations Supports Annual Mammography
News | Mammography | August 22, 2017
When to initiate screening for breast cancer, how often to screen, and how long to screen are questions that continue...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Overlay Init